bioAffinity appoints broker-dealer for equity financing
bioAffinity Technologies has entered into a placement agreement with WallachBeth Capital to sell up to $4 million in securities, including common stock and warrants, despite a projected filing date of October 8, 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed